148 related articles for article (PubMed ID: 26551699)
21. Understanding the role of NRF2-regulated miRNAs in human malignancies.
Shah NM; Rushworth SA; Murray MY; Bowles KM; MacEwan DJ
Oncotarget; 2013 Aug; 4(8):1130-42. PubMed ID: 24029073
[TBL] [Abstract][Full Text] [Related]
22. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation.
Ye M; Wang Q; Zhang W; Li Z; Wang Y; Hu R
Biochem Cell Biol; 2014 Oct; 92(5):337-48. PubMed ID: 25247252
[TBL] [Abstract][Full Text] [Related]
23. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
Vollrath V; Wielandt AM; Iruretagoyena M; Chianale J
Biochem J; 2006 May; 395(3):599-609. PubMed ID: 16426233
[TBL] [Abstract][Full Text] [Related]
24. The Keap1-Nrf2 system and diabetes mellitus.
Uruno A; Yagishita Y; Yamamoto M
Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
[TBL] [Abstract][Full Text] [Related]
25. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
[TBL] [Abstract][Full Text] [Related]
26. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
Sun Z; Zhang S; Chan JY; Zhang DD
Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
[TBL] [Abstract][Full Text] [Related]
27. Compensatory role of the Nrf2-ARE pathway against paraquat toxicity: Relevance of 26S proteasome activity.
Izumi Y; Yamamoto N; Matsushima S; Yamamoto T; Takada-Takatori Y; Akaike A; Kume T
J Pharmacol Sci; 2015 Nov; 129(3):150-9. PubMed ID: 26598004
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
Arlt A; Sebens S; Krebs S; Geismann C; Grossmann M; Kruse ML; Schreiber S; Schäfer H
Oncogene; 2013 Oct; 32(40):4825-35. PubMed ID: 23108405
[TBL] [Abstract][Full Text] [Related]
29. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice.
Hu X; Roberts JR; Apopa PL; Kan YW; Ma Q
Mol Cell Biol; 2006 Feb; 26(3):940-54. PubMed ID: 16428448
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways.
Yang YC; Lii CK; Wei YL; Li CC; Lu CY; Liu KL; Chen HW
J Nutr Biochem; 2013 Jan; 24(1):204-12. PubMed ID: 22901690
[TBL] [Abstract][Full Text] [Related]
31. Nrf2 protects against airway disorders.
Cho HY; Kleeberger SR
Toxicol Appl Pharmacol; 2010 Apr; 244(1):43-56. PubMed ID: 19646463
[TBL] [Abstract][Full Text] [Related]
32. NRF2, a Transcription Factor for Stress Response and Beyond.
He F; Ru X; Wen T
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640524
[TBL] [Abstract][Full Text] [Related]
33. Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress.
Quiles JM; Pepin ME; Sunny S; Shelar SB; Challa AK; Dalley B; Hoidal JR; Pogwizd SM; Wende AR; Rajasekaran NS
Sci Rep; 2021 Jun; 11(1):11977. PubMed ID: 34099738
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
Prasad KN
J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
[TBL] [Abstract][Full Text] [Related]
35. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
Cuevas S; Yang Y; Konkalmatt P; Asico LD; Feranil J; Jones J; Villar VA; Armando I; Jose PA
Hypertension; 2015 Jun; 65(6):1251-7. PubMed ID: 25895590
[TBL] [Abstract][Full Text] [Related]
36. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
38. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.
Leonard MO; Kieran NE; Howell K; Burne MJ; Varadarajan R; Dhakshinamoorthy S; Porter AG; O'Farrelly C; Rabb H; Taylor CT
FASEB J; 2006 Dec; 20(14):2624-6. PubMed ID: 17142801
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Sequence Variation on Genome-wide NRF2 Binding--New Target Genes and Regulatory SNPs.
Kuosmanen SM; Viitala S; Laitinen T; Peräkylä M; Pölönen P; Kansanen E; Leinonen H; Raju S; Wienecke-Baldacchino A; Närvänen A; Poso A; Heinäniemi M; Heikkinen S; Levonen AL
Nucleic Acids Res; 2016 Feb; 44(4):1760-75. PubMed ID: 26826707
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor Nrf2: examination of nuclear protein levels by immunoblotting and promoter response element binding by chromatin immunoprecipitation (ChIP).
Shay KP; Smith EJ; Hagen TM
Curr Protoc Toxicol; 2010 Aug; Chapter 17():Unit17.13. PubMed ID: 23045018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
